Drug Profile
Vaccina virus immuneglobulins - China Biologic Products
Latest Information Update: 13 Jan 2022
Price :
$50
*
At a glance
- Originator China Biologic Products
- Class Anti-infectives; Anti-inflammatories; Antibacterials; Antidementias; Antifibrotics; Antivirals; Eye disorder therapies; Immunoglobulins; Immunoproteins; Serum globulins; Skin disorder therapies; Vascular disorder therapies
- Mechanism of Action Amyloid beta-protein inhibitors; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Vaccinia virus infections
Most Recent Events
- 03 Dec 2012 Preclinical development is ongoing in China